The independent source for health policy research, polling, and news.
31,161 - 31,180 of 112,390 Results
The company, which provides software to businesses in hopes of selling them health-insurance plans, made false statements to investors about whether its employees were properly licensed, according to the Securities and Exchange Commission.
The deal reflects a blurring of traditional boundaries in health care as companies try to adjust to the ever-changing and uncertain marketplace.
The challenge, which could affect 400,000 who gained coverage when Arizona opted to accept the federal health law's option to expand eligibility for Medicaid, is based on an argument that the legislature needed a two-thirds majority to pass the expansion. Lower courts have rejected the claim. In other Medicaid news, a look at Maine's referendum, Kentucky's waiver request and controversies in Mississippi and Louisiana.
Congress missed a September deadline to renew funding for the popular program, but states had enough funds to give themselves a buffer zone. They're quickly running out, though.
In nearly all of the 2,722 counties included in a recent report, some consumers will be able to obtain free health insurance because they qualify for larger federal premium subsidies that cover the full cost of a plan now that President Donald Trump has stopped cost-sharing payments to insurers. In other health law news: what the marketplaces are going to be like for consumers this year; navigator funding; what Americans want the path forward to be; and more.
The effort is designed to see what regulations are getting in the way of doctors' ability to spend time with patients. In other industry news, some hospitals and doctors that once complained about requirements for bundled payments are revising their assessments, and an experiment to keep nursing home residents out of the hospital is showing promise.
The emergency declaration “falls far short of actions that are needed to immediately address the magnitude and scope of this epidemic,” says Michael Botticelli, executive director of the Grayken Center for Addiction at Boston Medical Center. Media outlets cover reactions out of Pennsylvania, Ohio, California, Illinois and Virginia as well.
While some criticize the lack of money behind the Trump administration's public health emergency move, others are excited for the light it will shine on the opioid epidemic.
Instead, President Donald Trump declared the epidemic a public health emergency, which is more limited status in terms of what federal and state officials can do to address the problem. Media outlets take a look at what exactly the move entails.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Opinion writers examine aspects of the health reform debate.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from Massachusetts, California, Pennsylvania, Texas, Puerto Rico, Maryland, Colorado, Minnesota and Florida.
Chicago-area hospitals are joining forces but what effect will it have for patients? Meanwhile, a new Massachusetts health bill would pit large hospitals in the state against smaller ones.
It might not sound impressive, but tens of thousands of human diseases can be traced back to a mistake with just one letter in the DNA. In other public health news: more from Reuters in its series on selling dead bodies; the legacy of abuse toward minorities in health studies; gun safety; cholesterol; arsenic; and more.
There's not one factor that experts can point fingers at--rather it's a host of issues, including bias from doctors and less care in early trimesters.
The FDA will issue guidance for development of new MAT options, promote efforts to decrease the stigma surrounding medication used to treat substance abuse disorders, and take further steps to promote the use of existing therapies, Commissioner Scott Gottlieb said. Meanwhile, lawmakers want the DEA to take on more authority to help fight the epidemic.
Meanwhile, recent mumps outbreaks have prompted the Centers for Disease Control and Prevention to recommend that people at risk get a third dose of the vaccine.
PhRMA is already pushing back on the measure saying it would let the government decide what medicines patients can get. In other news, an advocacy group is challenging Gilead's patents on the hepatitis C drug Sovaldi.
© 2026 KFF